OverviewSuggest Edit

PacBio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. The Company provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges.

TypePublic
Founded2004
HQMenlo Park, US
Websitepacb.com

Latest Updates

Employees (est.) (Feb 2019)456
Revenue (FY, 2018)$78.6 M(-15%)
Share Price (Mar 2019)$7.3

Pacific Biosciences of California Office Locations

Pacific Biosciences of California has offices in Menlo Park and Irvine
Menlo Park, US (HQ)
1380 Willow Rd
Irvine, US
4143 Health Sciences Rd
Show all (2)
Report incorrect company information

Pacific Biosciences of California Financials and Metrics

Pacific Biosciences of California Revenue

Embed Graph
View revenue for all periods
Pacific Biosciences of California's revenue was reported to be $78.63 m in FY, 2018
USD

Revenue (FY, 2018)

78.6m

Gross profit (FY, 2018)

25.1m

Gross profit margin (FY, 2018), %

31.9%

Net income (FY, 2018)

(102.6m)

EBIT (FY, 2018)

(101.0m)

Market capitalization (22-Mar-2019)

1.1b

Closing stock price (22-Mar-2019)

7.3

Cash (31-Dec-2018)

18.8m

EV

1.1b
Pacific Biosciences of California's current market capitalization is $1.1 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

28.2m60.6m92.8m90.7m93.5m78.6m

Revenue growth, %

115%53%(2%)

Cost of goods sold

21.8m37.2m39.3m46.6m58.8m53.5m

Gross profit

6.4m23.4m53.5m44.2m34.7m25.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

7.4m11.6m11.4m20.6m17.6m24.9m13.9m19.1m20.7m25.1m24.9m20.1m23.5m19.4m21.6m18.2m

Cost of goods sold

6.2m9.0m8.3m7.5m11.7m10.4m7.4m9.6m10.1m12.5m16.0m12.1m15.3m12.1m12.7m15.0m

Gross profit

1.2m2.7m3.1m13.2m5.9m14.5m6.6m9.5m10.6m12.6m8.9m8.0m8.2m7.3m8.9m3.2m

Gross profit Margin, %

17%23%27%64%34%58%47%50%51%50%36%40%35%38%41%18%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

26.4m36.4m33.6m16.8m16.5m18.8m

Accounts Receivable

2.7m3.4m5.2m11.4m13.4m8.6m

Inventories

10.1m1.7m11.0m15.6m23.1m17.9m

Current Assets

126.5m117.8m110.5m109.0m101.6m131.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

64.8m41.3m28.2m35.4m30.3m25.9m27.2m20.1m24.8m22.8m29.0m36.5m25.9m25.5m23.1m38.1m

Accounts Receivable

3.8m3.4m4.3m2.4m5.3m4.0m4.2m8.0m10.4m11.8m10.4m9.5m8.9m8.5m7.4m6.4m

Inventories

9.8m8.3m9.4m11.4m13.5m12.0m11.6m12.2m14.2m16.5m15.3m17.3m18.2m25.9m23.4m19.7m

Current Assets

141.8m132.1m119.9m114.1m99.5m90.2m86.2m119.1m138.1m122.5m88.3m132.9m113.6m115.7m96.4m143.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(79.3m)(66.2m)(31.7m)(74.4m)(92.2m)

Depreciation and Amortization

5.6m4.2m3.7m3.9m8.4m

Inventories

(60.0k)(1.3m)(2.5m)(6.2m)(8.4m)

Accounts Payable

(1.3m)3.9m(716.0k)3.4m764.0k
USDY, 2018

EV/EBIT

-11 x

EV/CFO

-23.4 x

Revenue/Employee

175.9k

Financial Leverage

1.5 x
Show all financial metrics

Pacific Biosciences of California Operating Metrics

FY, 2016

Patents (Foreign)

133

Patents (US)

221

Patents Pending

187
Show all operating metrics

Pacific Biosciences of California Revenue Breakdown

Embed Graph

Pacific Biosciences of California revenue breakdown by geographic segment: 21.9% from Asia, 22.1% from Europe and 56.0% from North America

Report incorrect company information

Pacific Biosciences of California Online and Social Media Presence

Embed Graph
Report incorrect company information

Pacific Biosciences of California News and Updates

Global DNA Sequencing Products Markets Report 2011-2018 & 2019-2024 Featuring Illumina, Thermo Fisher Scientific, Roche Diagnostics, Pacific Biosciences of California & Beckman Coulter

DUBLIN, Feb. 27, 2019 /PRNewswire/ -- The "DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering. The global DNA sequencing products market was worth around US$ 4 Billion...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB

NEW YORK, Dec. 6, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors of Pacific Biosciences of California, Inc....

Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call

MENLO PARK, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results on Thursday, November 1, 2018, at 4:30pm Eastern Time.

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.  Pacific Biosciences also intends to grant the underwriters a 30-day option…
Report incorrect company information

Pacific Biosciences of California Blogs

Two New Reference Genomes Expand Potential for Millet as Super Cereal Crop

New high-quality reference genomes recently published by two different scientific teams in China, will enable breeders to mine the novel genetic traits of one of the world's oldest, hardiest domesticated crops - and potential "super cereal" - broomcorn millet.

New Progress in Representing Population Diversity in Human Genomes

We’re seeing real progress in efforts to better characterize genomic population diversity. That’s particularly good news in light of mounting concerns about the implications of having genomic databases that over-represent individuals of European ancestry

From the Smallest Organisms to the Most Complex, the Future is Bright for Plant & Animal Sequencing

For the thousands of scientists who attended The Plant and Animal Genome Conference in San Diego this January, the sentiment seemed to be “ask not if PacBio is for you, but how PacBio can work best for you.” We share highlights and video recordings from the conference, which included early data from…

AGBT 2019: First Look at Early Access Results from the Sequel II System

Attendees of AGBT 2019 got a sneak peek at data from our soon-to-be-released Sequel II System and the latest results using the HiFi reads with the circular consensus sequencing (CCS) mode. Unable to attend? We've collected highlights of the event, including recordings of several talks.

GIAB Expands Variant Call Sets with SMRT Sequencing Results

Two AGBT posters show how the Genome in a Bottle team has expanded its benchmark set to include additional small and large variants.

Scientists Uncover Epilepsy-Causing Structural Variant with SMRT Sequencing

A new publication describes the use of SMRT Sequencing to discover a 12.4 kb pathogenic structural variant that causes progressive myoclonic epilepsy. The variant was detected in a repetitive, GC-rich region after several other methods failed to find the answer.
Show more

Pacific Biosciences of California Frequently Asked Questions

  • When was Pacific Biosciences of California founded?

    Pacific Biosciences of California was founded in 2004.

  • How many employees does Pacific Biosciences of California have?

    Pacific Biosciences of California has 456 employees.

  • What is Pacific Biosciences of California revenue?

    Latest Pacific Biosciences of California annual revenue is $78.6 m.

  • What is Pacific Biosciences of California revenue per employee?

    Latest Pacific Biosciences of California revenue per employee is $172.4 k.

  • Who are Pacific Biosciences of California competitors?

    Competitors of Pacific Biosciences of California include Oxford Nanopore Technologies, Medgate and RaySearch Laboratories.

  • Where is Pacific Biosciences of California headquarters?

    Pacific Biosciences of California headquarters is located at 1380 Willow Rd, Menlo Park.

  • Where are Pacific Biosciences of California offices?

    Pacific Biosciences of California has offices in Menlo Park and Irvine.

  • How many offices does Pacific Biosciences of California have?

    Pacific Biosciences of California has 2 offices.